Hey Ole Bob... yep I read the whole thing,that's why I posted it. The FDA is sure not my favorite organization. Would be nice if they could keep the things off the market that are harmful ,which they often fail to do, but skip the efficacy testing and leave it to me to say if it works or not, and if not, I'll deal with it..I'm a big boy now. Below is a FDA abstract on silver... sure wish they would speak about elec.CS..... I'd like to read the whole study. Can you request [and receive] studies from them <<<<<<<<<<<<<<<<<<<<>>>>>>>>>>>>>> Silver products for medical indications: risk-benefit assessment. Fung MC, Bowen DL J Toxicol Clin Toxicol 1996 34:119-26 BROWSE : J Toxicol Clin Toxicol Volume 34 Issue 1VIEW : MEDLINE, full MEDLINE, related records Abstract BACKGROUND: Legitimate medicinal use of silver-containing products has dramatically diminished over the last several decades. Recently, however, some manufacturers have begun to enthusiastically promote oral colloidal silver proteins as mineral supplements and for prevention and treatment of many diseases. Indiscriminate use of silver products can lead to toxicity such as argyria. OBJECTIVE: To assist health care professionals in a risk versus benefit assessment of over-the-counter silver-containing products, we herein examine the following issues: historical uses, chemistry, pharmacology, clinical toxicology, case reports of adverse events in the literature, and the recent promotion of over-the-counter silver products. Other sources of silver exposure (including environmental and dietary) and EPA exposure standards are discussed. A list of currently available silver products is provided for easy reference and screening. CONCLUSIONS: We emphasize the lack of established effectiveness and potential toxicity of these products. MeSH Animal; Argyria; Female; Human; Male; Maximum Allowable Concentration; Risk Assessment; Silver Compounds; Silver Proteins; Treatment Outcome CAS Registry Number (Substance Name) 0 (Silver Compounds) 0 (Silver Proteins) Author Address Center of Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA. Abstracted by Journal Article; Review; Review, TutorialPublication Type Journal Article; Review; Review, TutorialISSN 0731-3810Country UNITED STATESLanguage engJournal Code KANDate of Entry 19960701Entry Month 199607Journal Subset AIM; IMClass Update Date 2000Last Revision Date 20001218Unique Identifier 96223892 Resea
larry tankersley; Gainesville,Florida USA -- The silver-list is a moderated forum for discussion of colloidal silver. To join or quit silver-list or silver-digest send an e-mail message to: [email protected] -or- [email protected] with the word subscribe or unsubscribe in the SUBJECT line. To post, address your message to: [email protected] Silver-list archive: http://escribe.com/health/thesilverlist/index.html List maintainer: Mike Devour <[email protected]>
